Sexually Transmitted Diseases Treatment Guidelines, 2015
MMWR Recommendations and Reports June 2015 V.64 N.RR-3
Workowski KA, Bolan GA
These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 30–May 2, 2013. The information in this report updates the Sexually Transmitted Diseases Treatment Guidelines, 2010 (MMWR Recomm Rep 2010;59 [No. RR–12]).
These updated guidelines discuss
1) alternative treatment regimens for Neisseria gonorrhoeae;
2) the use of nucleic acid amplification tests for the diagnosis of trichomoniasis;
3) alternative treatment options for genital warts;
4) the role of Mycoplasma genitalium in urethritis/cervicitis and treatment-related implications;
5) updated HPV vaccine recommendations and counseling messages;
6) the management of persons who are transgender;
7) annual testing for hepatitis C in persons with HIV infection;
8) updated recommendations for diagnostic evaluation of urethritis; and
9) retesting to detect repeat infection.
Physicians and other health-care providers can use these guidelines to assist in the prevention and treatment of STDs.
Entry filed under: Antimicrobianos, Bacterias, Biología Molecular, CONSENSOS, Epidemiología, GUIDELINES, Hepatitis C, HIV/SIDA, Infecciones de transmision sexual, Infecciones Gin/Obs, Infecciones parasitarias, Infecciones urinarias, Infecciones virales, Inmunizaciones, Metodos diagnosticos, Update. Tags: .
Low level of hepatitis B virus screening among patients receiving chemotherapy. A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission.